IRA Impacts: Cancer treatment research and development

Last month marked the one-year anniversary of the reignited Cancer Moonshot, the White House ’s ambitious goal of reducing the death rate from cancer by at least 50% over the next 25 years. Much of thepositive trends in declining cancer mortality, down 33% since peaking in 1991, is driven in large part by innovative medicines researched and developed by America ’s biopharmaceutical companies. But more needs to be done. Eradicating the hundreds of different diseases that make up cancer is a commitment we share with the administration, and the science has never been more promising.
Source: The Catalyst - Category: Pharmaceuticals Tags: Research and Development Cancer Government Price Setting Source Type: news